Developers face new Claude Code limits as Cursor and OpenCode lose access, giving you clear steps to switch or handle added ...
22hon MSN
Novel immunotherapy demonstrates early potential to overcome resistance to immune checkpoint therapy
According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback